Detalhe da pesquisa
1.
Toripalimab (anti-PD-1) versus high-dose interferon-α2b as adjuvant therapy in resected mucosal melanoma: a phase II randomized trial.
Ann Oncol
; 33(10): 1061-1070, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35842199
2.
[Preliminary effects of toripalimab combined with axitinib in the treatment of advanced renal cell carcinoma].
Zhonghua Yi Xue Za Zhi
; 102(2): 136-140, 2022 Jan 11.
Artigo
em Zh
| MEDLINE | ID: mdl-35012303
3.
[Impact of first-line chemotherapy on renal function in patients with advanced upper tract urothelial carcinoma].
Zhonghua Yi Xue Za Zhi
; 98(32): 2574-2578, 2018 Aug 28.
Artigo
em Zh
| MEDLINE | ID: mdl-30220142
4.
The natural history and patterns of metastases from mucosal melanoma: an analysis of 706 prospectively-followed patients.
Ann Oncol
; 28(4): 868-873, 2017 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28039178
5.
BRAF inhibitors: efficacious and tolerable in BRAF-mutant acral and mucosal melanoma.
Neoplasma
; 64(4): 626-632, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28485171
6.
[Efficacy and the multivariate analysis of sunitinib as first-line treatment in patients with metastatic renal cell carcinoma].
Zhonghua Yi Xue Za Zhi
; 96(38): 3053-3056, 2016 Oct 18.
Artigo
em Zh
| MEDLINE | ID: mdl-27784444